首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.
【2h】

GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.

机译:GLQ223:一种在急性和慢性感染的淋巴细胞和单核吞噬细胞谱系中感染人类免疫缺陷病毒的抑制剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

GLQ223 is a highly purified, formulated preparation of trichosanthin, a 26-kDa plant-derived ribosome-inactivating protein with potent inhibitory activity against human immunodeficiency virus (HIV) in vitro. The compound produced concentration-dependent inhibition of HIV replication in acutely infected cultures of T-lymphoblastoid cells (VB cell line). Treatment with GLQ223 selectively reduced levels of detectable viral proteins compared to total cellular protein synthesis and produced a selective decrease in levels of viral RNA relative to total cellular RNA in acutely infected cells. Substantial inhibition of viral replication was observed at concentrations of GLQ223 that showed little inhibition of parallel uninfected cultures. Selective anti-HIV activity was also observed in cultures of primary monocyte/macrophages chronically infected with HIV in vitro. When freshly drawn blood samples from HIV-infected patients were treated with a single 3-hr exposure to GLQ223. HIV replication was blocked for at least 5 days in subsequently cultured monocyte/macrophages, without further treatment. The anti-HIV activity of GLQ223 in both acutely and chronically infected cells and its activity in cells of both lymphoid and mononuclear phagocytic lineage make it an interesting candidate as a potential therapeutic agent in HIV infection and AIDS.
机译:GLQ223是天花粉蛋白的高纯度配方制剂,天花粉蛋白是一种26 kDa植物来源的核糖体失活蛋白,在体外对人免疫缺陷病毒(HIV)具有强抑制活性。该化合物在急性感染的T淋巴母细胞(VB细胞系)培养物中产生了对HIV复制的浓度依赖性抑制。与总细胞蛋白合成相比,用GLQ223处理可选择性降低可检测病毒蛋白的水平,并且相对于急性感染细胞中总细胞RNA而言,病毒RNA的水平选择性降低。在GLQ223的浓度下观察到了对病毒复制的实质性抑制,而对GLQ223的平行未感染培养物几乎没有抑制作用。在体外长期感染HIV的原代单核细胞/巨噬细胞的培养物中也观察到选择性的抗HIV活性。当从感染了HIV的患者中抽取新鲜血液样本时,应将其与GLQ223接触3小时。未经进一步处理,随后培养的单核细胞/巨噬细胞中HIV复制被阻止至少5天。 GLQ223在急性和慢性感染细胞中的抗HIV活性及其在淋巴和单核吞噬细胞谱系细胞中的活性都使其成为HIV感染和AIDS潜在治疗剂的有趣候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号